Latest Cost Savings News

Bega Group is consolidating its Strathmerton cheese operations into its Ridge Street site by mid-2026, targeting significant cost savings and operational efficiencies.

Aurizon reports a mixed freight volume performance to April 2025 alongside progress on $50 million in annualised cost savings and a potential subordinated hybrid capital raise.

MyEco Group has secured $1.6 million through unsecured convertible notes to support a strategic operational restructure aimed at reducing costs and scaling production. This capital raise complements existing cash reserves and aims to improve margins while minimising shareholder dilution.

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

Platinum Investment Management's Funds Under Management fell to $9.65 billion in April amid market pressures and retail outflows, while a major $958 million institutional mandate termination prompts accelerated cost savings.

Synertec Corporation reports a 7.7% revenue increase in FY25 Q3, highlights robust Powerhouse technology performance during extreme weather, and secures a US patent for its LNG Custody Transfer System.

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.

Barton Gold Holdings has released an Optimised Scoping Study for its Tunkillia Gold Project, revealing significant improvements in project economics, including a sub-one-year payback and reduced capital expenditure. The study paves the way for accelerated feasibility work and funding efforts.

Yowie Group Ltd has responded to ASX queries detailing a significant revenue impact from reduced store facings and clarified complex loan arrangements with Keybridge Capital Limited amid ongoing solvency concerns.

Anagenics Limited has completed a significant restructuring to simplify operations and issued 35 million shares to FOS Capital as part of this process. The company confirms its going concern status and outlines plans for organic and acquisitive growth over the next year.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy by executing three CAR-T term sheets and completing technical due diligence, while implementing cost-cutting measures and seeking new capital amid a tough financing environment.

Spenda Limited reported a robust Q3 FY25 with cash receipts soaring 160% year-on-year despite a strategic sale of its invoice finance loan book. The company secured a $3 million loan facility and forecasts a record-breaking quarter ahead.